U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry RACEMIC
Molecular Formula C10H19N3O2
Molecular Weight 213.2768
Optical Activity ( + / - )
Defined Stereocenters 0 / 1
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of GUANADREL

SMILES

NC(=N)NCC1COC2(CCCCC2)O1

InChI

InChIKey=HPBNRIOWIXYZFK-UHFFFAOYSA-N
InChI=1S/C10H19N3O2/c11-9(12)13-6-8-7-14-10(15-8)4-2-1-3-5-10/h8H,1-7H2,(H4,11,12,13)

HIDE SMILES / InChI

Description

Guanadrel is a postganglionic adrenergic blocking agent. Uptake of guanadrel and storage in sympathetic neurons occurs via the norepinephrine pump or transporter. Guanadrel slowly displaces norepinephrine from its storage in nerve endings and thereby blocks the release of norepinephrine normally produced by nerve stimulation. The reduction in neurotransmitter release in response to sympathetic nerve stimulation, as a result of catecholamine depletion, leads to reduced arteriolar vasoconstriction, especially the reflex increase in sympathetic tone that occurs with a change in position. Guanadrel is used to treat and control hypertension.

Originator

Approval Year

Targets

Primary TargetPharmacologyConditionPotency

Conditions

ConditionModalityTargetsHighest PhaseProduct
Primary
Hylorel

Cmax

ValueDoseCo-administeredAnalytePopulation
28.4 ng/mL
50 mg single, oral
GUANADREL plasma
Homo sapiens
42 ng/mL
25 mg single, oral
GUANADREL plasma
Homo sapiens
73 ng/mL
25 mg single, oral
GUANADREL plasma
Homo sapiens

AUC

ValueDoseCo-administeredAnalytePopulation
404.9 μg × h/mL
50 mg single, oral
GUANADREL plasma
Homo sapiens
234 ng × h/mL
25 mg single, oral
GUANADREL plasma
Homo sapiens
627 ng × h/mL
25 mg single, oral
GUANADREL plasma
Homo sapiens

T1/2

ValueDoseCo-administeredAnalytePopulation
3.69 h
25 mg single, oral
GUANADREL plasma
Homo sapiens
6.8 h
25 mg single, oral
GUANADREL plasma
Homo sapiens

Doses

AEs

PubMed

Sample Use Guides

In Vivo Use Guide
For high blood pressure: Adults—At first, 5 milligrams (mg) two times a day. Then, may be increased up to 20 to 75 mg a day, divided into two to four doses.
Route of Administration: Oral
In Vitro Use Guide
Unknown